Skip to content

Clinical trials

Phase 2 trials in Mexico with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2 Status: Unknown status Country / region: Mexico Clear all

63 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20051
20065
20071
20091
20102
20111
20123
20132
20142
20154
20162
20172
20188
20195
20205
20218
20225
20231
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status63

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hospital Universitario Dr. Jose E. Gonzalez8
University of Guadalajara6
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran4
Centro Universitario de Ciencias de la Salud, Mexico3
Coordinación de Investigación en Salud, Mexico3
Instituto Nacional de Cardiologia Ignacio Chavez3
Hospital General Naval de Alta Especialidad - Escuela Medico Naval2
Instituto Nacional de Cancerologia de Mexico2
National Institute of Cancerología2
Universidad Autonoma de San Luis Potosí2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms5
COVID-195
Obesity4
Diabetes Mellitus, Type 23
Hodgkin Disease2
Liver Cirrhosis2
Overweight2
Precursor Cell Lymphoblastic Leukemia-Lymphoma2
Purpura, Thrombocytopenic, Idiopathic2
Acquired Immunodeficiency Syndrome1

Trials

Showing 1 to 25 of 63. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.